PMID int64 35.7M 36.4M | Title/Abstract stringlengths 22 8.78k | MeshTerms stringlengths 7 101 | SemanticTypes stringlengths 4 64 |
|---|---|---|---|
36,290,946 | progress develop biosensor base peptid copper coordin interact copper ion activ center natur enzym play import role mani physiolog process copper ion base catalyst mimic activ enzym wide use field industri catalysi sens devic import class small biolog molecul peptid advantag easi synthesi excel biocompat low toxic good... | D003300;D015374 | T123;T121;T075;T196;T059 |
36,290,945 | g optrod bio interfac non invas optic cell stimul design evalu biocompat potenti efficaci biolog applic reli bio interact graphen nanoparticl biolog tissu analyz modul cellular devic level activ requir non invas electr stimul cell address need g optrod bio interfac base graphen develop devic use light stimul cell witho... | D006108 | T196;T109 |
36,290,944 | ingeni fabric ag fill porous anod alumina film power ser substrat effici detect biolog organ molecul surfac enhanc raman scatter ser wide use effect detect various biolog organ molecul detect method need analyt adsorb onto specif metal nanostructur eg ag nanoparticl substrat contain structur call ser substrat user frie... | D012834;D053768 | T196;T073 |
36,290,943 | clinic applic epitheli sodium channel enac biomark arteri hypertens arteri hypertens htn global public health concern import risk factor cardiovascular diseas renal failur previous report overexpress enac plasma membran human platelet hallmark htn doubl blind studi open popul n evalu sensit specif diagnost assay base g... | D053768;D006973 | T047;T073 |
36,290,942 | colorimetr detect sar cov virus covid artifici saliva use polydiacetylen paper strip spread resurg sar cov virus covid diseas threaten human health social relat prevent covid diseas part reli fabric low cost point care poc sens technolog rapid select detect sar cov virus report colorimetr paper base polydiacetylen pda ... | D000086382;D015374 | T075;T047;T059;T067 |
36,290,941 | silico investig snr dermi sensit optimum dual channel near infrar glucos sensor design differ skin color diabet serious health condit requir patient regular monitor blood glucos level make develop practic compact non invas techniqu essenti optic glucos sensor specif nir sensor advantag non invas compact inexpens user f... | D012880;D008543 | T123;T109;T042 |
36,290,940 | enhanc respons foodborn pathogen detect au nanoparticl decor zno nanosheet gas sensor listeria monocytogen hazard foodborn pathogen abl caus acut mening enceph sepsi human effici detect hydroxi butanon verifi biomark exhal listeria monocytogen feasibl evalu whether bacteria contain food herein develop outstand hydroxi ... | D015034;D053768;D000080745 | T121;T197;T073 |
36,290,939 | dual color fluoresc hydrogel microspher combin smartphon visual detect lactat sinc difficult human eye distinguish two ident color lt variat bright mono color fluoresc hydrogel microspher limit detect lactat herein prepar novel dual color fluoresc hydrogel microspher achiev hue transform microspher prepar introduc fluo... | D019187;D045663 | T197;T073 |
36,290,938 | electrochem microneedl innov instrument health care signific part drug therapi mode drug transport attract worldwid attent effici drug deliveri method mark improv drug absorpt rate also reduc risk infect recent microneedl combin advantag subcutan inject administr transderm patch administr painless also high drug absorp... | D057968;D009339 | T074 |
36,290,937 | high densiti gold nanoparticl implant mgfe ldh nanoflow assist later flow immuno dipstick assay visual detect human epididym protein timeli accur diagnosi diseas higher patient surviv rate human epididym protein great signific biomark concern reflect ovarian cancer herein prepar novel optic label use later flow immuno ... | D006046;D053768 | T121;T196;T073 |
36,290,936 | ho tio nanobelt electrod high select sensit detect cancer mirna design engin effect electrod materi critic develop electrochem sensor present studi ho tio nanobelt synthes alkalin hydrotherm process structur morpholog investig x ray diffract xrd field emiss scan electron microscop fesem measur ho tio nanobelt show dist... | D035683;D009369 | T123;T191;T114 |
36,290,935 | design optim magneto plasmon sandwich biosensor integr within microfluid devic design magneto plasmon biosensor immunodetect antigen minut sampl volum spheric gold nanoparticl aunp magnet bead mb conjug goat anti rabbit igg antibodi ab capabl recogn model target rabbit igg rigg aunp bioconjug use optic detect probe mb ... | D053768;D015374 | T059;T073;T075 |
36,290,934 | state art advanc nanomedicin diagnosi treatment bladder cancer bladder cancer common malign tumor urinari system cystoscopi urin cytolog ct routin diagnost method howev problem low sensit difficulti stage must urgent supplement novel diagnost method surgeri intraves instil system chemotherapi radiotherapi main clinic t... | D001749 | T191 |
36,290,933 | revers migrat fluoresc probe precis dynam evalu cell mitochondri membran potenti mitochondri membran potenti mmp mito provid charg gradient requir mitochondri function key indic cellular health chang mmp close relat diseas monitor mmp thus vital patholog studi drug develop howev current fluoresc probe mmp reli sole cel... | D005456;D012313 | T130;T114 |
36,290,932 | upconvers fluoresc nanoprob base fret sensit determin shigella shigella typic foodborn pathogen strong surviv environ food lead infecti diseas yet rapid detect technolog high select sensit remain challeng studi complementari strand modifi upconvers nanoparticl ucnp offer stabl yellow green fluoresc nm excit nm laser im... | D052157;D053768;D053758;D012760 | T007;T073;T114 |
36,290,931 | innov sandwich type biosensor toward sensit select monitor arachidonoylglycerol human plasma sampl use p cd aunp ddt amplific agent new immuno platform recognit endocannabinoid real sampl work ag success detect human plasma sampl use new sandwich type electrochem immun devic base poli cyclodextrin p cd function aunp dd... | D015374;D053768;D047392 | T059;T073;T075;T109 |
36,290,930 | silicon photomultipli high dynam rang high sensit sensor bio photon applic work overview silicon photomultipli sipm view defin import bio photon clinic applic sipm benchmark common photodetector name pin diod avalanch photodetector apd compar respect import circuit design paramet shown care select design bias voltag ov... | D055095;D017785 | T090;T167 |
36,290,929 | neonicotinoid microspher immunosens profil applic honeybe bee relat matric neonicotinoid common use insecticid due effect howev non target insect especi bee also affect neonicotinoid therefor neonicotinoid applic contribut declin bee popul worldwid present studi describ develop novel competit fluoresc microspher base s... | D007306 | T131 |
36,290,928 | stage skin cancer base hyperspectr microscop imag machin learn skin cancer common type cancer general divid basal cell carcinoma bcc squamous cell carcinoma scc malign melanoma mm incid skin cancer continu increas worldwid recent year earli detect great reduc morbid mortal hyperspectr microscop imag hmi technolog use p... | D012878;D002280;D008545;D002294 | T191 |
36,290,927 | biosensor drug deliveri oncotheranost use inorgan synthet biogen magnet nanoparticl magnet nanocarri attract attent translat oncolog due abil employ tumor diagnost therapi review summar data applic synthet biogen magnet nanoparticl mnps oncolog theranost relat area basic type mnps includ synthesi approach structur phys... | D058185;D053758;D015374;D009369 | T073;T075;T191;T059;T130 |
36,290,926 | cholesterol chip studi cholesterol protein interact use spr cholesterol import lipid anim membran bind hydrophob pocket within mani solubl protein transport protein membran bound protein studi cholesterol protein interact aqueous solut complic cholesterol low solubl often requir organ co solvent surfact addit report sy... | D020349;D053823 | T063;T123;T116 |
36,290,925 | sensit immunodetect assay use antibodi specif staphylococc enterotoxin b produc baculovirus express staphylococc enterotoxin b seb potent bacteri toxin caus inflammatori stimul toxic shock thus necessari detect seb food environment sampl develop sensit immunodetect system use monoclon antibodi mab studi first employ ba... | D013211;D001427 | T123;T007;T116;T131 |
36,290,924 | cervic imag low resourc set review cervic cancer one signific global health inequ time fourth common cancer women worldwid disproport affect develop countri diseas burden sometim refer prevent cancer progress slowli provid window time routin screen pre cancer lesion identifi treat high mortal rate attribut mani reason ... | D002583 | T191 |
36,290,923 | integr power free self contain microfluid chip fiber optic particl plasmon reson aptasensor rapid detect sar cov nucleocapsid protein global pandem covid creat unrival need sensit rapid point care test poct method detect infecti virus novel coronavirus sar cov nucleocapsid protein n protein one abund structur protein v... | D000086382;D015374 | T075;T047;T059;T067 |
36,290,922 | dielectrophoresi approach increas sensit reduc respons time suppress nonspecif bind biosensor perform receptor base biosensor often limit either diffus analyt caus unreason long assay time lack specif limit sensit due nois nonspecif bind altern current ac electrokinet effect biosens increas field research dedic address... | D015374 | T059;T075 |
36,290,921 | ruthenium nickel molybd decor porous graphit carbon nitrid high sensit cardiac troponin biosensor two dimension layer materi function monometal bimetal dopant excel materi fabric clinic use biosensor herein report synthesi ruthenium nanoparticl runp nickel molybd nanorod nimoo nrs function porous graphit carbon nitrid ... | D012428;D006108;D015374 | T196;T059;T075;T109 |
36,290,920 | voltammetri peak track longer last refer electrod free electrochem biosensor electrochem aptam base sensor offer reagent free continu analyt measur often suffer poor longev potenti drift even robust electrod system present simpl softwar enabl approach track redox report peak electrochem aptam base sensor use measur red... | D015374;D052157 | T059;T075;T114 |
36,290,919 | smartphon base biosensor non invas monitor total hemoglobin concentr human high accuraci paper propos smartphon base biosensor detect human total hemoglobin concentr vivo high accuraci compar exist biosensor use measur hemoglobin concentr smartphon base sensor util camera memori comput power phone thus cost larg reduc ... | D000068997;D015374 | T059;T073;T075 |
36,290,918 | detect alpha fetoprotein use aptam base sensor alpha fetoprotein afp wide known common use protein biomark liver cancer diagnosi earli stage therefor develop high sensit reliabl method afp detect essenti demand practic applic herein two type aptam base afp detect method ie optic electrochem biosensor review detail opti... | D015374;D052157 | T059;T075;T114 |
36,290,917 | fluoresc signal readout crisprca biosensor nucleic acid detect crisprca system use extens nucleic acid detect applic particular tran cleavag activ sever cas effector found crisprca system combin multipl signal readout techniqu develop various molecular diagnost applic fluoresc wide util domin read techniqu crispr biose... | D015374;D009696 | T123;T059;T075;T114 |
36,290,916 | core shell au tio multi wall carbon nanotub base sensor electroanalyt determin h human blood serum saliva hydrogen peroxid h sensor develop base core shell gold titanium dioxid nanoparticl multi wall carbon nanotub modifi glassi carbon electrod au tio mwcntsgce core shell au tio materi prepar character use scan electro... | D037742 | T104;T073 |
36,290,915 | spectral properti echo tautomer milrinon applic fe ion sens protein stain knowledg spectral properti tautom milrinon mlr solvent solid state well light condit critic import theoret practic point view herein investig spectral properti mlr differ condit use uv vis fluoresc spectroscopi experiment result demonstr mlr unde... | D011522;D005456 | T196;T130 |
36,290,914 | sensor base carbon nanotub field effect transistor chemic biolog analys nano biochem sensor play import role detect biomark relat human diseas carbon nanotub cnts becom import factor promot vigor develop field due special structur excel electron properti paper focus appli carbon nanotub field effect transistor cnt fet ... | D037742;D009696 | T104;T123;T073;T114 |
36,290,913 | label free aptasensor detect fipronil base black phosphorus nanosheet label free fipronil aptasensor built base polylysin black phosphorus nanosheet composit pll bpnss au nanoparticl aunp pll bp modifi glassi carbon electrod gce fabric combin bp nss pll includ consider quantiti nh au nanoparticl aunp place onto gce pll... | D052157;D015374;D053768 | T075;T059;T073;T114 |
36,290,912 | strong improv sensit phosphoresc base optic oxygen sensor exploit nano porous substrat sensit one crucial factor determin qualiti fluorescencephosphoresc base gas sensor estim measur respons refer measur optic intens sensor absenc presenc analyt molecul various concentr analyt work demonstr phosphoresc base optic oxyge... | D011166 | T123;T109 |
36,290,911 | select specif aptam rivaroxaban util label free electrochem aptasens use gold nanoparticl first announc applic clinic sampl analysi first time novel aptam design util select detect rivaroxaban riv use integr bioinformat biosens technolog select aptam sequenc tag gga aga gaa gga cat atg atg act cac aac tgg acg aac gta c... | D052157;D015374;D053768 | T075;T059;T073;T114 |
36,290,910 | electr wheelchair manipul system use ssvep base bci system peopl motor disabl use joystick control electr wheelchair howev suffer multipl sclerosi amyotroph later sclerosi may requir method control electr wheelchair studi implement electroencephalographi eeg base brain comput interfac bci system steadi state visual evo... | D062207;D014910 | T074 |
36,290,909 | electrochem immunosensor determin procalcitonin use gold graphen interdigit electrod procalcitonin pct consid sepsi infect biomark herein interdigit electrochem immunosensor determin pct develop interdigit electrod made laser engrav graphen electrod decor gold legeau nano scan electron microscopi indic legeau nano fabr... | D006108;D015374;D053768 | T073;T075;T109;T196;T059 |
36,290,908 | impact chemosensit outcom brain metastas small cell lung cancer retrospect analysi purpos studi investig prognost differ patient small cell lung cancer sclc differ chemosensit first line chemotherapi develop brain metastasi bm first site progress | D055752;D001932;D008175 | T191 |
36,290,907 | influenc activ surveil gleason score upgrad prognosi low favor intermedi risk prostat cancer studi focus link activ surveil gleason score upgrad gsu impact prognosi patient prostat cancer pca studi aim analyz effect durat gsu prognost valu base risk stratif elig patient risk stratifi accord aua guidelin low risk lr fav... | D017430;D011471 | T129;T191;T126;T116 |
36,290,906 | long term toxic immun checkpoint inhibitor ici melanoma patient ici therapi great improv patient outcom melanoma cost immun relat advers event ira data chronic ira especi real world set current limit perform retrospect chart review adult patient melanoma treat least one cycl ici regimen adjuv metastat set patient recei... | D000074322;D008545 | T129;T121;T191;T116 |
36,290,905 | sleep disturb affect immun factor clinic liver cancer patient sleep wake disturb preval patient liver cancer direct evid associ relat biolog mechan studi assess qualiti sleep describ preval sleep disturb patient differ etiolog liver cancer especi explor whether sleep qualiti influenc immun factor | D012893;D008113 | T047;T191;T048 |
36,290,904 | improv integr palliat radiotherapi support care narrat review palliat radiotherapi prt known effect reliev cancer relat symptom howev mani studi clinic practic show sever barrier hinder use worsen qualiti patient support prt various solut propos overcom barrier train prt support palliat care specialist train palliat ca... | D018787;D009369 | T191;T091 |
36,290,903 | pemigatinib intrahepat cholangiocarcinoma work progress cholangiocarcinoma cca second frequent primari liver cancer follow hepatocellular carcinoma hcc progress molecular understand cca led develop sever agent includ fgfr inhibitor pemigatinib whose approv mark new era hepatobiliari malign howev number question remain ... | D001650;D006528;D008113;D018281 | T191 |
36,290,902 | effect radiotherapi pancreat ductal adenocarcinoma patient liver metastas radiotherapi studi treatment local advanc pancreat ductal adenocarcinoma pdac studi analyz effect radiotherapi pdac patient liver metastas studi aim determin whether pdac patient liver metastas improv surviv radiotherapi treatment | D021441;D010190;D008113 | T191 |
36,290,901 | improv time treatment advanc non small cell lung cancer patient faster singl gene egfr test use idylla egfr test platform patient advanc stage non small cell lung cancer nsclc may benefit short time treatment ttt predict biomark test perform prior treatment recommend various intern expert consensus bodi genet test time... | D002289;D008175 | T191 |
36,290,900 | f fdg petct petmr patient adren lymphoma systemat review literatur collect case present studi aim assess exist data primari adren lymphoma pal evalu fdg pet describ small monocentr seri case systemat analysi made use pubm web scienc databas report data role fdg petct patient suspici known adren lymphoma qualiti paper a... | D019788;D008223 | T191;T130;T109 |
36,290,899 | boron neutron captur therapi clinic applic research progress boron neutron captur therapi bnct binari modal use treat varieti malign use neutron irradi boron b nuclei enter tumor cell produc high linear energi transfer let alpha particl recoil li nuclei b n li therefor import part bnct select deliv larg number b tumor ... | D016754;D001932;D008545;D006258 | T061;T191 |
36,290,898 | stereotact bodi radiat therapi lung liver oligometastas breast cancer toxic data prospect non random phase ii trial report matur toxic data phase ii non random trial use sbrt lung liver oligometastas | D016634;D001943;D008113 | T061;T191 |
36,290,897 | complic risk factor en bloc resect spinal tumor retrospect analysi patient treat singl institut en bloc resect consist surgic remov vertebr tumor singl piec suffici margin improv surviv reduc recurr rate procedur technic demand correl high complic rate purpos studi investig risk factor complic en bloc resect evalu bene... | D013125 | T191 |
36,290,896 | outcom high dose stereotact ablat radiotherapi allmultipl site oligometastat renal cell cancer patient stereotact ablat bodi radiotherapi sabr one treatment option oligometastat renal cell carcinoma rcc limit lack data evalu high dose sabr allmultipl site | D002292;D016634;D007680 | T061;T191 |
36,290,895 | therapeut advanc rare alk fusion non small cell lung cancer non small cell lung cancer nsclc account approxim lung cancer case lead caus cancer relat death despit advanc chemotherapi immunotherapi prognosi advanc patient remain poor discoveri oncogen driver mutat anaplast lymphoma kinas alk mutat mean subset patient op... | D002289;D008175 | T191 |
36,290,894 | lymphadenectomi benefit small cell carcinoma ovari popul base analysi small cell carcinoma ovari scco rare type ovarian cancer high aggress optim treatment modal remain elus studi aim comprehens investig surviv impact clinic characterist treatment includ lymphadenectomi scco retrospect cohort studi perform includ patie... | D018288;D055752;D008175 | T191 |
36,290,893 | promis immun treatment advanc cutan squamous cell carcinoma cemiplimab real world experi global sar cov pandem cutan squamous cell carcinoma cscc second frequent non melanoma skin cancer standard curat treatment surgic resect treatment local advanc metastat diseas apart radiotherapi current base cemiplimab cemiplimab d... | D002294;D012878;D000074322;D000086382 | T121;T129;T116;T067;T191;T047 |
36,290,892 | mind base stress reduct influenc qualiti life anxieti depress women diagnos breast cancer review breast cancer common form cancer diseas worldwid treatment lead varieti physiolog psycholog side effect review investig question mind base stress reduct mbsr stress manag program influenc qualiti life anxieti depress women ... | D064866;D001943 | T191;T041 |
36,290,891 | health behavior cancer prevent among adult li fraumeni syndrom relat germani cohort descript li fraumeni syndrom lfs rare high penetr cancer predisposit syndrom cps caus pathogen variant pvs tp physic activ pa mediterranean diet lead cancer reduct surviv benefit increas qualiti life qol yet unstudi among lfs tp pv carr... | D016864 | T047 |
36,290,890 | effect exercis intervent gait function young survivor osteosarcoma megaendoprosthesi lower extrem result pilot random control trial progait limb preserv megaendoprosthesi adolesc young adult aya bone tumor associ function limit gait abnorm progait trial evalu effect exercis program gait function qualiti life function s... | D012516;D001859 | T191 |
36,290,889 | geriatr g score associ surviv outcom older patient advanc prostat cancer adher prospect studi meet uro network introduct androgen receptor pathway inhibitor arpi increas offer older patient prostat cancer pc howev prognost factor relev outcom arpi still littl investig method materi meet uro network adher prospect multi... | D064129 | T191 |
36,290,888 | cancer patient first treat chemotherapi like receiv surgeri pandem due ramp cancer surgeri earli pandem mani newli diagnos patient receiv treatment first aim quantifi pandem relat shift rate surgeri follow chemotherapi retrospect popul base cohort studi involv adult diagnos cancer januari novemb ontario canada receiv c... | D000086382;D001943 | T047;T191;T067 |
36,290,887 | rational efficaci safeti evid lenvatinib pembrolizumab associ anaplast thyroid carcinoma anaplast thyroid carcinoma atc high aggress malign tumor poor overal prognosi despit multimod therapi atc extrem rare random control studi publish metastat diseas thyrosin kinas inhibitor especi lenvatinib immun checkpoint inhibito... | D065646;D013964 | T191 |
36,290,886 | clinic manag financi toxic identifi opportun experienti insight cancer survivor caregiv social worker perspect cancer survivor caregiv social worker key stakehold clinic manag financi toxic ft critic identifi opportun better ft manag semi structur interview cancer survivor caregiv focus group social worker undertaken u... | D000073116;D009369 | T201;T191;T101 |
36,290,885 | clinic factor associ long term surviv metastat melanoma treat anti pd alon combin ipilimumab immun checkpoint inhibitor ici treatment metastat melanoma mm offer last overal surviv os benefit subset patient howev outcom remain poor non respond clinic predictor long term surviv remain elus util alberta immunotherapi data... | D000074322;D008545;D016609 | T129;T121;T191;T116 |
36,290,884 | singl cell transcriptom endotheli cell upper lower human esophag squamous cell carcinoma esophag squamous cell carcinoma escc type progress distant metastat tumor target anti angiogen gene could effect hinder escc develop metastasi wherea escc locat upper lower esophagus show differ respons clinic treatment suggest esc... | D000077277;D004938;D010739 | T191;T126;T116 |
36,290,883 | outcom earli transit low risk thyroid cancer patient specialist primari care recent publish clinic pathway manag thyroid cancer outlin criteria transit low risk patient primari care within one five year diagnosi howev discharg pattern among endocrinologist remain heterogen lack consensus regard post treatment care thyr... | D013954;D013964 | T125;T121;T191;T116 |
36,290,882 | siglec new perspect therapi target human giant cell tumor bone main featur giant cell tumor bone gctb frequent recurr aggress osteolysi lead poor prognosi patient although treatment method gctb scrape resect effect inhibit diseas tendenc toward malign transform remain therefor import identifi new treatment method gctb ... | D018212;D001859 | T191 |
36,290,881 | postop patient report outcom uniport video assist thoracoscop surgeri use periop symptom assess lung surgeri scale studi aim use new special inventori lung surgeri patient evalu postop symptom function status identifi factor may affect uniport video assist thoracoscop surgeri vat singl center longitudin cohort observ s... | D020775;D008175 | T061;T191 |
36,290,880 | plasmacyt pleural effus major present angioimmunoblast cell lymphoma case report angioimmunoblast cell lymphoma one peripher cell lymphoma reactiv plasma cell occasion observ aitl patient peripher blood bone marrow plasmacyt pleural effus present aitl report mechan plasmacyt pleural effus fulli understood present year ... | D007119;D016411;D010996 | T047;T191 |
36,290,879 | apprais health technolog assess agenc econom evalu submit part reimburs dossier oncolog treatment evid canada uk australia public fund healthcar system includ canada unit kingdom uk australia often use health technolog assess hta inform drug reimburs decis make base dossier submit manufactur hta agenc issu public avail... | D013673 | T058 |
36,290,878 | manag prognosi patient recurr persistentprogress uterin carcinosarcoma uterin carcinosarcoma uc high aggress gynecolog malign recurr persistentprogress diseas usual fatal aim investig manag prognosi patient clinic record uc patient june april retrospect review stage assign figo stage system univari multivari analys use... | D002296;D014594 | T191 |
36,290,877 | predictor function recoveri among musculoskelet oncolog patient undergo lower extrem endoprosthet reconstruct function outcom import oncolog patient undergo lower extrem reconstruct object current studi describ patient report function surgeri identifi predictor postop function musculoskelet oncolog patient undergo lowe... | D012983;D012509;D005870 | T191 |
36,290,876 | understand treatment pattern outcom among patient de novo unresect local advanc metastat urotheli cancer popul level retrospect analysi alberta canada despit high diseas burden real world data treatment pattern patient unresect local advanc metastat urotheli carcinoma lamuc canada limit retrospect longitudin cohort stu... | D002295;D001749 | T191 |
36,290,875 | access cancer drug canada lung cancer multipl subtyp identifi myriad new effect therapi provid fertil ground highlight issu relat oncolog drug access canada | D000970;D008175 | T121;T191;T109 |
36,290,874 | mediterranean diet support intervent cancer patient current evid futur direct cancer current repres lead caus morbid mortal held respons one six death worldwid | D038441;D009369 | T061;T191 |
36,290,873 | predict signific prognost nutrit index serum albuminglobulin ratio overal surviv penil cancer patient undergo penectomi object assess valu use prognost nutrit index pni serum albuminglobulin ratio agr predict overal surviv os patient penil cancer pc undergo penectomi materi method retrospect analysi patient admit hospi... | D010412;D005916 | T123;T191;T116 |
36,290,872 | papillari tumor pineal region rare pediatr cns tumor case seri treat king fahad medic citi kfmc clinic behavior prognosi appropri treatment papillari tumor pineal region ptpr fulli defin due rariti tumor diagnosi ptpr may present clinic symptom includ headach obstruct hydrocephalus diplopia vomit lethargi well neurolog... | D010871;D001932;D010870 | T023;T191 |
36,290,871 | repurpos effect lu dotat treatment mantl cell lymphoma mantl cell lymphoma mcl uncommon subcategori non hodgkin lymphoma nhl pathogenesi primarili includ overexpress ccnd sox along molecular aberr lutetium lu dotat radiolabel somatostatin analogu use treatment gastrointestin neuroendocrin tumor clinic data support use ... | D020522;D002276 | T047;T191 |
36,290,870 | hepatocellular carcinoma alpha fetoprotein liver alloc transplant past present futur hepatocellular carcinoma hcc one lead indic liver transplant treatment choic due oncolog benefit patient advanc chronic liver diseas advcld small tumor last year hcc patient undergo liver transplant alpha fetoprotein afp increas appli ... | D006528;D016031;D008113 | T061;T191 |
36,290,869 | venetoclax combin azacitidin treatment newli diagnos acut myeloid leukemia canadian cost util analysi treatment acut myeloid leukemia aml typic involv intens chemotherapi ic howev unmet need approxim aml patient deem unfit inelig ic purpos studi evalu canadian perspect econom impact venetoclax combin azacitidin venaza ... | D001374;D015470 | T121;T191;T114 |
36,290,868 | peripher blood cell ratio prognost indic neoadjuv chemotherapi treat breast cancer cohort breast cancer repres heterogen condit interact host immun respons primari oncogen event impact diseas progress ratio system blood base immunocyt emerg clinic relev prognost biomark cancer patient nlr neutrophil lymphocyt ratio sho... | D020360;D064726 | T061;T191 |
36,290,867 | classif brain tumor magnet reson imag use vision transform ensembl autom classif brain tumor play import role support radiologist decis make recent vision transform vit base deep neural network architectur gain attent comput vision research domain owe tremend success transform model natur languag process henc studi abi... | D001932;D005910 | T191 |
36,290,866 | adher mediterranean diet nutrit status women breast cancer impact diseas progress recurr free patient surviv introduct nutrit status impact surviv patient cancer studi investig role nutrit status breast cancer surviv women breast cancer even fewer regard impact adher mediterranean diet md present studi aim assess nutri... | D038441;D001943 | T061;T191 |
36,290,865 | time trend upper gastrointestin cancer incid china analysi use age period cohort model aim studi investig upper gastrointestin cancer incid trend china joinpoint softwar evalu age effect cohort effect period effect use age period cohort model data obtain global burden diseas injuri risk factor studi crude incid rate cr... | D005770 | T191 |
36,290,864 | neuroendocrin carcinoma uterin cervix endometrium ovari show higher tendenc bone brain liver organotroph metastas neuroendocrin carcinoma nec femal genit tract rare aggress subtyp cancer still poor understood sever recent studi report pulmonari gastroenteropancreat neuroendocrin neoplasm show signific differ pattern me... | D002583;D018278;D018358;D008113 | T191 |
36,290,863 | neoadjuv chemo radiat use igrt patient local advanc gastric cancer goal studi see effect safe neoadjuv chemoradi imag guid imrt patient local advanc resect gastric cancer januari june patient local advanc ctct n gastric cancer treat neoadjuv chemoradiotherapi pumch peke union medic colleg hospit retrospect studi use co... | D013274;D061089;D013921;D000740 | T061;T047;T191 |
36,290,862 | small bowel adenocarcinoma year experi cancer center ottawa hospit toh background small bowel adenocarcinoma sba one predomin primari small bowel cancer dismal outcom aim report year experi sba manag region cancer centr canada method retrospect analys clinic patholog data patient diagnos sba ottawa hospit toh ottawa ca... | D007414;D000230 | T191 |
36,290,861 | dispar caus mortal older patient colorect cancer accord disabl status nationwid analysi although investig pattern cancer mortal import understand effect cancer popul health knowledg regard mortal cancer patient disabl scarc studi examin associ disabl status caus mortal older patient colorect cancer | D015179 | T191 |
36,290,860 | acut metastat spinal cord compress urgent surgeri versus radiotherapi treatment result predict versus actual result background context role radiotherapi versus surgeri treat acut metastat spinal cord compress amscc chang year purpos studi evalu neurolog function outcom follow urgent surgeri radiotherapi usfr versus urg... | D013117;D013125;D002277 | T047;T191 |
36,290,859 | tp mutat map advanc non small cell lung cancer real world retrospect cohort studi tp frequent mutat solid tumor basic mutat map mix particular aggress stage lung cancer | D002289;D008175 | T191 |
36,290,858 | wide dissect tran sulcal approach resect deep intra axial lesion eloqu brain area introduct resect intra axial tumor iat eloqu brain region risk major postop neurolog deficit awak craniotomi often use navig area howev patient inelig awak procedur tran sulcal approach tscal introduc reduc parenchym trauma tumor resect r... | D000622;D001932 | T123;T121;T116;T109;T191 |
36,290,857 | immunotherapi radiotherapi antitumor long rang weapon partnership unsolv challeng dose fraction volum therapeut sequenc immunotherapi modern oncolog treatment immun checkpoint inhibitor ici part clinic practic malign melanoma decad anti cytotox lymphocyt antigen ctla anti program cell death protein pd anti program deat... | D061026;D008545 | T129;T191;T116;T192 |
36,290,856 | implement primari hpv self test cervic screen program malaysia program rose lesson learnt move forward program rose remov obstacl cervic screen primari hpv base cervic screen program incorpor self sampl digit technolog ensur women link care develop base principl design think context malaysia program illustr import coll... | D002583;D030361;D000086382 | T047;T191;T067 |
36,290,855 | use breath analysi manag lung cancer readi primetim breath analysi promis non invas method detect manag lung cancer exhal breath contain complex mixtur volatil non volatil organ compound produc end product metabol sever studi explor pattern compound postul uniqu breath signatur emit set lung cancer studi evalu use gas ... | D008175;D055549 | T191;T109 |
36,290,854 | associ survivorship care plan patient report satisfact confid follow cancer care provid primari care provid survivorship care plan aim facilit smooth transit tertiari primari care set primari cancer treatment complet studi sought identifi sociodemograph factor associ receiv survivorship care plan examin relationship re... | D000359;D009369 | T058;T191 |
36,290,853 | prognost factor low grade glioma adult adult low grade glioma rare aggress patholog central nervous system characterist contribut patient life expect manag studi aim character identifi main prognost factor low grade glioma six year retrospect studi statist analyz demograph imag morphogenet characterist patient group ap... | D001932;D005910 | T191 |
36,290,852 | first second line treatment patient advanc hepatocellular carcinoma china systemat review chines nation guidelin recommend various system therapi patient advanc hepatocellular carcinoma hcc optim treatment select remain uncertain summar evid support system treatment chines patient advanc hcc perform systemat review use... | D006528;D059451;D008113 | T121;T191 |
36,290,851 | rapid review real world cost effect analys cancer intervent canada cost effect analysi ce analysi provid evid increment gain patient outcom cost new treatment intervent cancer care util real world data allow analys better reflect differ cost effect actual patient popul comorbid rang age oppos random control trial use r... | D000970;D009369 | T121;T191;T109 |
36,290,850 | current clinic practic precis medicin use comprehens genom profil test biliari tract cancer japan recent advanc next generat sequenc technolog comprehens genom profil cgp test design measur hundr cancer relat gene time wide introduc daili clinic practic patient whose tumor sampl fit tissu base cgp test blood base cgp t... | D057285;D001661 | T061;T191;T091 |
36,290,849 | precis oncolog canada convert vision realiti lesson intern program canada healthcar system like other worldwid immers process evolut attempt adapt convent framework health technolog assess hta fund model new landscap precis medicin oncolog particular need real world evid canada match necessari infrastructur technolog r... | D009369 | T191 |
36,290,848 | patholog report radic prostatectomi specimen follow iccr recommend impact electron report tool implement qualiti interdisciplinari communic larg univers hospit prostat cancer repres one common malign tumor male patient germani patholog report radic prostatectomi specimen follow structur process constitut excel prototyp... | D033183;D011468 | T062;T054;T061 |
36,290,847 | region survey merkel cell carcinoma plea uniform patient journey model diagnost therapeut pathway merkel cell carcinoma mcc rare aggress cutan neuroendocrin cancer usual affect elder immunosuppress sun expos area due rariti frequent unrecogn manag standard across medic center despit recent avail immunotherapi avelumab ... | D015266;D012878 | T191 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.